RiceBran Technologies (RIBT)

Market Cap	9.83M
Revenue (ttm)	35.70M
Net Income (ttm)	-11.75M
Shares Out	5.23M
EPS (ttm)	-0.23
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,711
Open	1.73
Previous Close	1.78
Day's Range	1.73 - 1.90
52-Week Range	1.57 - 9.00
Beta	0.20
Analysts	Sell
Price Target	4.59 (+144.1%)
Earnings Date	Oct 25, 2022

About RIBT

RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a prote...

• Industry: Food Products
• IPO Date: Sep 18, 1998
• CEO: Brent Rystrom
• Employees: 101
• Stock Exchange: NASDAQ
• Ticker Symbol: RIBT

Full Company Profile

Financial Performance

In 2021, RIBT's revenue was $31.13 million, an increase of 18.83% compared to the previous year's $26.20 million. Losses were -$8.95 million, -23.71% less than in 2020.

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for RIBT stock is "Sell." The 12-month stock price forecast is 4.59, which is an increase of 144.15% from the latest price.

Price Target

$4.59

(144.15% upside)

Analyst Consensus: Sell

Stock Forecasts